| | | | | | | | | | | | | | | | | | | | | |
<?xml version="1.0" standalone="yes" encoding="windows-1252"?> |
<!-- XBRL Document Created with XBRLMaster --> |
<!-- Version: 2.3.08 --> |
<!-- Based on XBRL 2.1 --> |
<!-- Date of creation: 08/23/2022 --> |
<!-- Software architectural design and coding: A'c Dharmapremananda Avt. --> |
<!-- Copyright (c) 2022 I-NET Business Solutions, Inc. All Rights Reserved. --> |
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"> |
| <link:roleRef roleURI="http://cigf5.com/role/Cover" xlink:href="cigf5-20220630.xsd#Cover" xlink:type="simple"/> |
| <link:roleRef roleURI="http://cigf5.com/role/CondensedBalanceSheets" xlink:href="cigf5-20220630.xsd#CondensedBalanceSheets" xlink:type="simple"/> |
| <link:roleRef roleURI="http://cigf5.com/role/CondensedBalanceSheetsParenthetical" xlink:href="cigf5-20220630.xsd#CondensedBalanceSheetsParenthetical" xlink:type="simple"/> |
| <link:roleRef roleURI="http://cigf5.com/role/CondensedStatementsOfOperationsUnaudited" xlink:href="cigf5-20220630.xsd#CondensedStatementsOfOperationsUnaudited" xlink:type="simple"/> |
| <link:roleRef roleURI="http://cigf5.com/role/CondensedStatementOfPartnersEquityUnaudited" xlink:href="cigf5-20220630.xsd#CondensedStatementOfPartnersEquityUnaudited" xlink:type="simple"/> |
| <link:roleRef roleURI="http://cigf5.com/role/CondensedStatementsOfCashFlowUnaudited" xlink:href="cigf5-20220630.xsd#CondensedStatementsOfCashFlowUnaudited" xlink:type="simple"/> |
| <link:roleRef roleURI="http://cigf5.com/role/Business" xlink:href="cigf5-20220630.xsd#Business" xlink:type="simple"/> |
| <link:roleRef roleURI="http://cigf5.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="cigf5-20220630.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple"/> |
| <link:roleRef roleURI="http://cigf5.com/role/InformationTechnologyMedicalTechnologyTelecommunicationsTechnologyInventoryManagementAndOtherBusinessEssentialCapitalEquipmentEquipment" xlink:href="cigf5-20220630.xsd#InformationTechnologyMedicalTechnologyTelecommunicationsTechnologyInventoryManagementAndOtherBusinessEssentialCapitalEquipmentEquipment" xlink:type="simple"/> |
| <link:roleRef roleURI="http://cigf5.com/role/RelatedPartyTransactions" xlink:href="cigf5-20220630.xsd#RelatedPartyTransactions" xlink:type="simple"/> |
| <link:roleRef roleURI="http://cigf5.com/role/NotesPayable" xlink:href="cigf5-20220630.xsd#NotesPayable" xlink:type="simple"/> |
| <link:roleRef roleURI="http://cigf5.com/role/SupplementalCashFlowInformation" xlink:href="cigf5-20220630.xsd#SupplementalCashFlowInformation" xlink:type="simple"/> |
| <link:roleRef roleURI="http://cigf5.com/role/CommitmentsAndContingencies" xlink:href="cigf5-20220630.xsd#CommitmentsAndContingencies" xlink:type="simple"/> |
| <link:roleRef roleURI="http://cigf5.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="cigf5-20220630.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple"/> |
| <link:roleRef roleURI="http://cigf5.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="cigf5-20220630.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple"/> |
| <link:roleRef roleURI="http://cigf5.com/role/InformationTechnologyMedicalTechnologyTelecommunicationsTechnologyInventoryManagementAndOtherBusinessEssentialCapitalEquipmentEquipmentTables" xlink:href="cigf5-20220630.xsd#InformationTechnologyMedicalTechnologyTelecommunicationsTechnologyInventoryManagementAndOtherBusinessEssentialCapitalEquipmentEquipmentTables" xlink:type="simple"/> |
| <link:roleRef roleURI="http://cigf5.com/role/RelatedPartyTransactionsTables" xlink:href="cigf5-20220630.xsd#RelatedPartyTransactionsTables" xlink:type="simple"/> |
| <link:roleRef roleURI="http://cigf5.com/role/NotesPayableTables" xlink:href="cigf5-20220630.xsd#NotesPayableTables" xlink:type="simple"/> |
| <link:roleRef roleURI="http://cigf5.com/role/SupplementalCashFlowInformationTables" xlink:href="cigf5-20220630.xsd#SupplementalCashFlowInformationTables" xlink:type="simple"/> |
| <link:roleRef roleURI="http://cigf5.com/role/BusinessDetailsNarrative" xlink:href="cigf5-20220630.xsd#BusinessDetailsNarrative" xlink:type="simple"/> |
| <link:roleRef roleURI="http://cigf5.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:href="cigf5-20220630.xsd#SummaryOfSignificantAccountingPoliciesDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://cigf5.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="cigf5-20220630.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple"/> |
| <link:roleRef roleURI="http://cigf5.com/role/InformationTechnologyMedicalTechnologyTelecommunicationsTechnologyInventoryManagementEquipmentAndOtherBusinessessentialCapitalEquipmentEquipmentDetails" xlink:href="cigf5-20220630.xsd#InformationTechnologyMedicalTechnologyTelecommunicationsTechnologyInventoryManagementEquipmentAndOtherBusinessessentialCapitalEquipmentEquipmentDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://cigf5.com/role/InformationTechnologyMedicalTechnologyTelecommunicationsTechnologyInventoryManagementEquipmentAndOtherBusinessessentialCapitalEquipmentEquipmentDetailsNarrative" xlink:href="cigf5-20220630.xsd#InformationTechnologyMedicalTechnologyTelecommunicationsTechnologyInventoryManagementEquipmentAndOtherBusinessessentialCapitalEquipmentEquipmentDetailsNarrative" xlink:type="simple"/> |
| <link:roleRef roleURI="http://cigf5.com/role/RelatedPartyTransactionsDetails" xlink:href="cigf5-20220630.xsd#RelatedPartyTransactionsDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://cigf5.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="cigf5-20220630.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple"/> |
| <link:roleRef roleURI="http://cigf5.com/role/NotesPayableDetails" xlink:href="cigf5-20220630.xsd#NotesPayableDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://cigf5.com/role/NotesPayableDetails1" xlink:href="cigf5-20220630.xsd#NotesPayableDetails1" xlink:type="simple"/> |
| <link:roleRef roleURI="http://cigf5.com/role/NotesPayableDetailsNarrative" xlink:href="cigf5-20220630.xsd#NotesPayableDetailsNarrative" xlink:type="simple"/> |
| <link:roleRef roleURI="http://cigf5.com/role/SupplementalCashFlowInformationDetails" xlink:href="cigf5-20220630.xsd#SupplementalCashFlowInformationDetails" xlink:type="simple"/> |
| <link:roleRef roleURI="http://cigf5.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="cigf5-20220630.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://cigf5.com/role/Cover" xlink:title="00000001 - Document - Document and Entity Information"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://cigf5.com/role/CondensedBalanceSheets" xlink:title="000002 - Statement - Condensed Balance Sheets"> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivables" xlink:label="loc_us-gaapOtherReceivables"/> |
| | <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapOtherReceivables" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansAndLeasesReceivableNetReportedAmount" xlink:label="loc_us-gaapLoansAndLeasesReceivableNetReportedAmount"/> |
| | <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapLoansAndLeasesReceivableNetReportedAmount" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashEquivalentsAtCarryingValue"/> |
| | <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/> |
| | <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" weight="-1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentGross" xlink:label="loc_us-gaapMachineryAndEquipmentGross"/> |
| | <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapMachineryAndEquipmentGross" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets"/> |
| | <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" weight="1"/> |
| | <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenue" xlink:label="loc_us-gaapDeferredRevenue"/> |
| | <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapDeferredRevenue" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableOtherCurrent" xlink:label="loc_us-gaapAccountsPayableOtherCurrent"/> |
| | <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapAccountsPayableOtherCurrent" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToOfficersOrStockholdersCurrentAndNoncurrent" xlink:label="loc_us-gaapDueToOfficersOrStockholdersCurrentAndNoncurrent"/> |
| | <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapDueToOfficersOrStockholdersCurrentAndNoncurrent" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent"/> |
| | <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnersCapital" xlink:label="loc_us-gaapPartnersCapital"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LimitedPartnersCapitalAccount" xlink:label="loc_us-gaapLimitedPartnersCapitalAccount"/> |
| | <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPartnersCapital" xlink:to="loc_us-gaapLimitedPartnersCapitalAccount" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralPartnersCapitalAccount" xlink:label="loc_us-gaapGeneralPartnersCapitalAccount"/> |
| | <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPartnersCapital" xlink:to="loc_us-gaapGeneralPartnersCapitalAccount" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity"/> |
| | <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapPartnersCapital" xlink:type="arc" weight="1"/> |
| | <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1"/> |
| | </link:calculationLink> |
| <link:calculationLink xlink:type="extended" xlink:role="http://cigf5.com/role/CondensedBalanceSheetsParenthetical" xlink:title="000003 - Statement - Condensed Balance Sheets (Parenthetical)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://cigf5.com/role/CondensedStatementsOfOperationsUnaudited" xlink:title="000004 - Statement - Condensed Statements of Operations (unaudited)"> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="cigf5-20220630.xsd#cigf5_SalesAndPropertyTaxesRevenue" xlink:label="loc_cigf5SalesAndPropertyTaxesRevenue"/> |
| | <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_cigf5SalesAndPropertyTaxesRevenue" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndOtherIncome" xlink:label="loc_us-gaapInterestAndOtherIncome"/> |
| | <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_us-gaapInterestAndOtherIncome" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesIncomeStatementLeaseRevenue" xlink:label="loc_us-gaapOperatingLeasesIncomeStatementLeaseRevenue"/> |
| | <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_us-gaapOperatingLeasesIncomeStatementLeaseRevenue" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts"/> |
| | <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="cigf5-20220630.xsd#cigf5_SalesAndPropertyTaxesExpense" xlink:label="loc_cigf5SalesAndPropertyTaxesExpense"/> |
| | <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_cigf5SalesAndPropertyTaxesExpense" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation"/> |
| | <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense"/> |
| | <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization" xlink:label="loc_us-gaapAdjustmentForAmortization"/> |
| | <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapAdjustmentForAmortization" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss"/> |
| | <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1"/> |
| | <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1"/> |
| | </link:calculationLink> |
| <link:calculationLink xlink:type="extended" xlink:role="http://cigf5.com/role/CondensedStatementOfPartnersEquityUnaudited" xlink:title="000005 - Statement - Condensed Statement of Partners' Equity (unaudited)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://cigf5.com/role/CondensedStatementsOfCashFlowUnaudited" xlink:title="000006 - Statement - Condensed Statements of Cash Flow (unaudited)"> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment"/> |
| | <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/> |
| | <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1"/> |
| | <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities"/> |
| | <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1"/> |
| | </link:calculationLink> |
| <link:calculationLink xlink:type="extended" xlink:role="http://cigf5.com/role/Business" xlink:title="000007 - Disclosure - Business"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://cigf5.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="000008 - Disclosure - Summary of Significant Accounting Policies"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://cigf5.com/role/InformationTechnologyMedicalTechnologyTelecommunicationsTechnologyInventoryManagementAndOtherBusinessEssentialCapitalEquipmentEquipment" xlink:title="000009 - Disclosure - Information Technology, Medical Technology, Telecommunications Technology, Inventory Management and Other Business-Essential Capital Equipment ("Equipment")"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://cigf5.com/role/RelatedPartyTransactions" xlink:title="000010 - Disclosure - Related Party Transactions"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://cigf5.com/role/NotesPayable" xlink:title="000011 - Disclosure - Notes Payable"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://cigf5.com/role/SupplementalCashFlowInformation" xlink:title="000012 - Disclosure - Supplemental Cash Flow Information"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://cigf5.com/role/CommitmentsAndContingencies" xlink:title="000013 - Disclosure - Commitments and Contingencies"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://cigf5.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="000014 - Disclosure - Summary of Significant Accounting Policies (Policies)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://cigf5.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="000015 - Disclosure - Summary of Significant Accounting Policies (Tables)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://cigf5.com/role/InformationTechnologyMedicalTechnologyTelecommunicationsTechnologyInventoryManagementAndOtherBusinessEssentialCapitalEquipmentEquipmentTables" xlink:title="000016 - Disclosure - Information Technology, Medical Technology, Telecommunications Technology, Inventory Management and Other Business-Essential Capital Equipment ("Equipment") (Tables)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://cigf5.com/role/RelatedPartyTransactionsTables" xlink:title="000017 - Disclosure - Related Party Transactions (Tables)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://cigf5.com/role/NotesPayableTables" xlink:title="000018 - Disclosure - Notes Payable (Tables)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://cigf5.com/role/SupplementalCashFlowInformationTables" xlink:title="000019 - Disclosure - Supplemental Cash Flow Information (Tables)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://cigf5.com/role/BusinessDetailsNarrative" xlink:title="000020 - Disclosure - Business (Details Narrative)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://cigf5.com/role/SummaryOfSignificantAccountingPoliciesDetails" xlink:title="000021 - Disclosure - Summary of Significant Accounting Policies (Details)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://cigf5.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="000022 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://cigf5.com/role/InformationTechnologyMedicalTechnologyTelecommunicationsTechnologyInventoryManagementEquipmentAndOtherBusinessessentialCapitalEquipmentEquipmentDetails" xlink:title="000023 - Disclosure - Information Technology Medical Technology Telecommunications Technology Inventory Management Equipment and other BusinessEssential Capital Equipment (Equipment) (Details)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://cigf5.com/role/InformationTechnologyMedicalTechnologyTelecommunicationsTechnologyInventoryManagementEquipmentAndOtherBusinessessentialCapitalEquipmentEquipmentDetailsNarrative" xlink:title="000024 - Disclosure - Information Technology Medical Technology Telecommunications Technology Inventory Management Equipment and other BusinessEssential Capital Equipment (Equipment) (Details Narrative)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://cigf5.com/role/RelatedPartyTransactionsDetails" xlink:title="000025 - Disclosure - Related Party Transactions (Details)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://cigf5.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="000026 - Disclosure - Related Party Transactions (Details Narrative)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://cigf5.com/role/NotesPayableDetails" xlink:title="000027 - Disclosure - Notes Payable (Details)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://cigf5.com/role/NotesPayableDetails1" xlink:title="000028 - Disclosure - Notes Payable (Details 1)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://cigf5.com/role/NotesPayableDetailsNarrative" xlink:title="000029 - Disclosure - Notes Payable (Details Narrative)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://cigf5.com/role/SupplementalCashFlowInformationDetails" xlink:title="000030 - Disclosure - Supplemental Cash Flow Information (Details)"/> |
| <link:calculationLink xlink:type="extended" xlink:role="http://cigf5.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="000031 - Disclosure - Commitments and Contingencies (Details Narrative)"/> |
| </link:linkbase> |